Joëlle M.
- Country
- Belgium
- Department
- ULB Hôpital Erasme
Research Overview
- Baricitinib Versus TNF Inhibitors for Venous Thromboembolism Risk in Rheumatoid Arthritis: Phase 3b/4 Active-Controlled Study
- Long-Term Safety, Tolerability, and Efficacy of Zasocitinib in Adults With Active Psoriatic Arthritis: A Phase 3 Extension Study
- Long-Term Extension Study of RO7790121 (Afimkibart) for Safety and Efficacy in Adults with Moderate-to-Severe Rheumatoid Arthritis
Data & Insights
Has run more than one trial at 172 of 371 partner sites.
Specializations
Rheumatoid Arthritis Research
Specializes in investigating innovative treatment approaches for early rheumatoid arthritis and moderate to severe rheumatoid arthritis. The investigator evaluates various therapeutic strategies including TNF blockade therapy and novel compounds like rosnilimab.
- COBRA-Slim treatment strategy
- Remission induction therapies
- Long-term disease management
Autoimmune Conditions
Conducts research in multiple autoimmune disorders, with particular focus on systemic lupus erythematosus and Primary Sjögren's Disease. Evaluates novel therapeutic agents including upadacitinib and efgartigimod.
- Disease activity assessment
- Systemic manifestations
- Long-term safety evaluation
Inflammatory Arthritis
Investigates therapeutic solutions for axial spondyloarthritis and psoriatic arthritis. Studies include evaluation of treatments such as filgotinib and zasocitinib for patients with active disease.
- Signs and symptoms management
- Treatment-naive patient populations
- Disease activity monitoring
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.